Related Experiment Video

Updated: Jun 27, 2026

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
06:42

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

Thioredoxin-1 is a novel and attractive therapeutic approach for various diseases including cardiovascular disorders

Ludivine Billiet1, Mustapha Rouis

  • 1UMR 7079 / Université Pierre et Marie Curie-Paris 6, Physiologie et Physiopathologie, Bât. A. 5eme étage/Case courrier 256, 7, Quai St-Bernard, 75252 Paris Cedex 5, France.

Cardiovascular & Hematological Disorders Drug Targets
|December 17, 2008
PubMed

Insights

Thioredoxin-1 (Trx-1) is a key antioxidant regulating cellular redox balance and protecting against oxidative stress. Increasing Trx-1 activity offers a promising therapeutic strategy for various diseases.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Medicine

Background:

  • Cellular reduction/oxidation (redox) balance is crucial for cellular function.
  • Thioredoxin-1 (Trx-1) is a primary antioxidant system involved in redox homeostasis.
  • Trx-1 regulates protein function, scavenges reactive oxygen species, and modulates transcription factors.

Purpose of the Study:

  • To highlight the critical role of Trx-1 in maintaining cellular redox balance.
  • To explore the regulatory interactions of Trx-1, including its modulation by VDUP-1/Txnip.
  • To discuss the potential of Trx-1 as a therapeutic target for oxidative stress-related pathologies.

Main Methods:

  • Literature review on Trx-1 function and regulation.
  • Analysis of studies investigating Trx-1 activity in various physiological and pathological conditions.
  • Examination of the relationship between Trx-1, VDUP-1/Txnip, and oxidative stress.

Main Results:

  • Trx-1 plays a multifaceted role in antioxidant defense and redox regulation.
  • Trx-1 activity is modulated by interactions with VDUP-1 (Txnip).
  • Elevated plasma Trx-1 levels show beneficial effects in preclinical models of disease.

Conclusions:

  • Oxidative stress is implicated in major pathologies like cardiovascular and cerebrovascular diseases.
  • Modulating Trx-1 activity represents a novel and attractive therapeutic approach.
  • Enhancing Trx-1 function could be a valuable strategy for treating diseases associated with redox imbalance.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...